One name under-$10 stock in the biotechnology and drugs complex that's starting to look very bullish is Amicus Therapeutics ( FOLD), which is focused on the discovery, development and commercialization of orally administered, small molecule drugs known as pharmacological chaperones for the treatment of rare diseases. This stock has been blazing a trail in 2012, with shares up over 38% so far. If you take a look at the chart for Amicus Therapeutics, you'll notice that this stock has been soaring since it hit a bottom at $2.10 in late November of last year. This stock has soared so much that its current price is quickly approaching $5 a share. This big run up in the stock is now pushing shares of FOLD up against some key breakout levels, that if hit, could lead to much higher prices. >>5 Stocks Poised to Break Out Market players should now watch FOLD for a sustained high-volume move and close above $4.71 and $5.10 (200-day) a share to trigger a breakout trade. Look for volume that registers near or above its three-month average action of 58,210 shares. At last check, volume for FOLD has already hit 89,000 shares today with the stock trading at around $4.96 a share. This now puts FOLD within range of taking out $5.10, which would be very bullish price action. You could be a buyer of FOLD off any weakness and simply use a mental stop that's just below $4.71 or that's near today's low of $4.34. You could also buy off strength if it takes out $5.10 soon, and simply use a mental stop right below that level. I would target a run back towards $6 to $7 a share, or possibly higher if we get a high-volume breakout over $5.10 for FOLD in the near future.